Late-onset Pompe disease primarily affects quality of life in physical health domains

被引:74
作者
Hagemans, MLC
Janssens, ACJW
Winkel, LPF
Sieradzan, KA
Reuser, AJJ
Van Doorn, PA
Van der Ploeg, AT
机构
[1] Erasmus MC Sophia, Dept Pediat, Div Metab Dis & Genet, NL-3015 GJ Rotterdam, Netherlands
[2] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[3] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands
关键词
D O I
10.1212/01.WNL.0000142597.69707.78
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate quality of life in an international population of patients with late-onset Pompe disease. Methods: Data on quality of life (SF-36), age, sex, disease duration, wheelchair use, and use of artificial ventilation were collected for 210 adults with Pompe disease from Australia, Germany, the Netherlands, the United Kingdom, and the United States. SF-36 scores were compared between countries and related to patient characteristics. In addition, for the Dutch subgroup (n = 51), comparisons with the general population and 1-year follow-up assessments were performed. Results: No significant differences between countries were found for the four physical health scales. Mean scores on the vitality, role functioning-emotional, and mental health scale differed between countries, but these differences were not consistent. Wheelchair use was associated with lower physical and social functioning scores (B = -23.6 and -15.1, p < 0.001), and the use of artificial ventilation with lower physical functioning scores (B = -8.4, p = 0.004). Patients reported significantly poorer quality of life than the general population on the physical functioning, role functioning-physical, general health, vitality, and social functioning scales. No significant differences in SF-36 scores were found between the baseline and 1-year follow-up measurement. Conclusions: Patients with late-onset Pompe disease are, on average, markedly affected on the physical health domains of quality of life, but score only slightly lower than the general population on the mental health domains.
引用
收藏
页码:1688 / 1692
页数:5
相关论文
共 19 条
[11]   Quality of life assessment in adults with type 1 Gaucher disease [J].
Masek, BJ ;
Sims, KB ;
Bove, CM ;
Korson, MS ;
Short, P ;
Norman, DK .
QUALITY OF LIFE RESEARCH, 1999, 8 (03) :263-268
[12]   Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention [J].
Miners, AH ;
Holmes, A ;
Sherr, L ;
Jenkinson, C ;
MacDermot, KD .
QUALITY OF LIFE RESEARCH, 2002, 11 (02) :127-133
[13]  
Ruta DA, 1998, BRIT J RHEUMATOL, V37, P425
[14]   Recombinant human α-glucosidase from rabbit milk in Pompe patients [J].
Van den Hout, H ;
Reuser, AJJ ;
Vulto, AG ;
Loonen, MCB ;
Cromme-Dijkhuis, A ;
Van der Ploeg, AT .
LANCET, 2000, 356 (9227) :397-398
[15]   The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature [J].
van den Hout, HMP ;
Hop, W ;
van Diggelen, OP ;
Smeitink, JAM ;
Smit, GPA ;
Poll-The, BTT ;
Bakker, HD ;
Loonen, MCB ;
de Klerk, JBC ;
Reuser, AJJ ;
van der Ploeg, AT .
PEDIATRICS, 2003, 112 (02) :332-340
[16]   Cross-cultural comparisons of the content of SF-36 translations across 10 countries:: Results from the IQOLA project [J].
Wagner, AK ;
Gandek, B ;
Aaronson, NK ;
Acquadro, C ;
Alonso, J ;
Apolone, G ;
Bullinger, M ;
Bjorner, J ;
Fukuhara, S ;
Kaasa, S ;
Leplège, A ;
Sullivan, M ;
Wood-Dauphinee, S ;
Ware, JE .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :925-932
[17]  
Ware J.E., 2003, SF 36 HLTH SURVEY MA
[18]   THE MOS 36-ITEM SHORT-FORM HEALTH SURVEY (SF-36) .1. CONCEPTUAL-FRAMEWORK AND ITEM SELECTION [J].
WARE, JE ;
SHERBOURNE, CD .
MEDICAL CARE, 1992, 30 (06) :473-483
[19]   Enzyme replacement therapy in late-onset Pompe's disease: A three-year follow-up [J].
Winkel, LPF ;
Van den Hout, JMP ;
Kamphoven, JHJ ;
Disseldorp, JAM ;
Remmerswaal, M ;
Arts, WFM ;
Loonen, MCB ;
Vulto, AG ;
Van Doorn, PA ;
De Jong, G ;
Hop, W ;
Smit, GPA ;
Shapira, SK ;
Boer, MA ;
van Diggelen, OP ;
Reuser, AJJ ;
Van der Ploeg, AT .
ANNALS OF NEUROLOGY, 2004, 55 (04) :495-502